Vaxcyte
THERAPEUTIC AREA
Vaccines
YEAR INVESTED
2017
STAGE
Public
WEBSITE
Vaxcyte is a vaccine innovation company developing broad-spectrum conjugate and novel protein vaccines to protect humankind from bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum, carrier-sparing pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease.
